Diosmetin enhances the sensitivity of radiotherapy by suppressing homologous recombination in endometrial cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2020;70(1):7–30. Epub 2020/ 01/09. PubMed PMID: 31912902.
   PubMed Web of Science ®Google Scholar
• Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 2019;19(9):510–521. Epub 2019/ 08/08. PubMed PMID: 31388127.
   PubMed Web of Science ®Google Scholar
• Wright JD, Barrena Medel NI, Sehouli J, et al. Contemporary management of endometrial cancer. Lancet. 2012;379(9823):1352–1360. Epub 2012/ 03/27. PubMed PMID: 22444602.
   PubMed Web of Science ®Google Scholar
• Brooks RA, Fleming GF, Lastra RR, et al. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019;69(4):258–279. Epub 2019/ 05/11. PubMed PMID: 31074865.
   PubMed Web of Science ®Google Scholar
• Mao Z, Bozzella M, Seluanov A, et al. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle (Georgetown, Tex). 2008;7(18):2902–2906. Epub 2008/ 09/05. PubMed PMID: 18769152; PubMed Central PMCID: PMCPmc2754209.
   PubMed Web of Science ®Google Scholar
• Rosenberg P, Wingren S, Simonsen E, et al. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator. Gynecol Oncol. 1989;35(1):50–54. Epub 1989/ 10/01. PubMed PMID: 2792902.
   PubMed Web of Science ®Google Scholar
• Scully R, Panday A, Elango R, et al. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019. Epub 2019/ 07/03. PubMed PMID: 31263220. DOI:10.1038/s41580-019-0152-0
   PubMed Web of Science ®Google Scholar
• Raderschall E, Stout K, Freier S, et al. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res. 2002;62(1):219–225. Epub 2002/ 01/10. PubMed PMID: 11782381.
   PubMed Web of Science ®Google Scholar
• Maacke H, Jost K, Opitz S, et al. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 2000;19(23):2791–2795. PubMed PMID: WOS:000087318500009.
   PubMed Web of Science ®Google Scholar
• Mao Z, Jiang Y, Liu X, et al. DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia (New York, NY). 2009;11(7):683–691. Epub 2009/ 07/02. PubMed PMID: 19568413; PubMed Central PMCID: PMCPmc2697354.
   PubMed Web of Science ®Google Scholar
• Meirinhos J, Silva BM, Valentao P, et al. Analysis and quantification of flavonoidic compounds from Portuguese olive (Olea europaea L.) leaf cultivars. Nat Prod Res. 2005;19(2):189–195. Epub 2005/ 02/18. PubMed PMID: 15715265.
   PubMed Web of Science ®Google Scholar
• Patel K, Gadewar M, Tahilyani V, et al. A review on pharmacological and analytical aspects of diosmetin: a concise report. Chin J Integr Med. 2013;19(10):792–800. Epub 2013/ 10/05. PubMed PMID: 24092244.
   PubMed Web of Science ®Google Scholar
• Kahn SR. The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs. Arch Intern Med. 1998;158(21):2315–2323. Epub 1998/ 11/25. PubMed PMID: 9827782.
   PubMedGoogle Scholar
• Chen Y, Wang Y, Liu M, et al. Diosmetin exhibits anti-proliferative and anti-inflammatory effects on TNF-alpha-stimulated human rheumatoid arthritis fibroblast-like synoviocytes through regulating the Akt and NF-kappaB signaling pathways. Phytother Res. 2019. Epub 2019/ 12/14. PubMed PMID: 31833613. DOI:10.1002/ptr.6596
   Web of Science ®Google Scholar
• Liao WZ, Ning ZX, Chen LY, et al. Intracellular antioxidant detoxifying effects of diosmetin on 2,2-Azobis(2-amidinopropane) Dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation. J Agr Food Chem. 2014;62(34):8648–8654. PubMed PMID: WOS:000340992100014. .
   PubMed Web of Science ®Google Scholar
• Ma A, Zhang R. Diosmetin inhibits cell proliferation, induces cell apoptosis and cell cycle arrest in liver cancer. Cancer Manag Res. 2020;12:3537–3546. Epub 2020/ 06/18. PubMed PMID: 32547191; PubMed Central PMCID: PMCPMC7244522.
   PubMed Web of Science ®Google Scholar
• Oak C, Khalifa AO, Isali I, et al. Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. Int J Oncol. 2018;53(2):835–843. PubMed PMID: WOS:000440581500033.
   PubMed Web of Science ®Google Scholar
• Wang C, Li S, Ren H, et al. Anti-proliferation and pro-apoptotic effects of diosmetin via modulating cell cycle arrest and mitochondria-mediated intrinsic apoptotic pathway in MDA-MB-231 Cells. Med Sci Monit. 2019;25:4639–4647. Epub 2019/ 06/23. PubMed PMID: 31228347; PubMed Central PMCID: PMCPMC6601365.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shao Z, Liao Y, et al. Targeting SKP2/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation. Eur J Pharmacol. 2020;173366. Epub 2020/ 07/18. doi:10.1016/j.ejphar.2020.173366
   PubMed Web of Science ®Google Scholar
• Liu J, Wen X, Liu B, et al. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9. Mol Med Rep. 2016;13(3):2401–2408. Epub 2016/ 02/06. PubMed PMID: 26847170; PubMed Central PMCID: PMCPMC4768952.
   PubMed Web of Science ®Google Scholar
• Ciolino HP, Wang TTY, Yeh GC. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 Activity. Cancer Res. 1998 JULY 1;58:2754–2760.
   PubMed Web of Science ®Google Scholar
• Androutsopoulos VP, Mahale S, Arroo RR, et al. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. Oncol Rep. 2009;21(6):1525–1528. Epub 2009/ 05/09. PubMed PMID: 19424633.
   PubMed Web of Science ®Google Scholar
• Srivastava M, Raghavan SC. DNA double-strand break repair inhibitors as cancer therapeutics. Chem Biol. 2015;22(1):17–29. Epub 2015/ 01/13. PubMed PMID: 25579208.
   PubMedGoogle Scholar
• Seluanov A, Mao Z, Gorbunova V. Analysis of DNA double-strand break (DSB) repair in mammalian cells. J Vis Exp. 2010:43. Epub 2010/ 09/25. PubMed PMID: 20864925; PubMed Central PMCID: PMCPmc3157866. DOI:10.3791/2002.
   Google Scholar
• Mao Z, Hine C, Tian X, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science (New York, NY). 2011;332(6036):1443–1446. Epub 2011/ 06/18. PubMed PMID: 21680843.
   Google Scholar
• Zhang L, Zhang F, Zhang W, et al. Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells. Cancer Biol Ther. 2015;16(11):1585–1592. Epub 2015/ 09/19. PubMed PMID: 26382920; PubMed Central PMCID: PMCPMC4846143.
   PubMed Web of Science ®Google Scholar
• Scully R, Panday A, Elango R, et al. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Bio. 2019;20(11):698–714. PubMed PMID: WOS:000492310900009.
   PubMed Web of Science ®Google Scholar
• Goldstein M, Kastan MB. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med. 2015;66:129–143. Epub 2014/ 11/26. PubMed PMID: 25423595. .
   PubMed Web of Science ®Google Scholar
• Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421(6922):499–506. PubMed PMID: WOS:000180670600036.
   PubMed Web of Science ®Google Scholar
• Ahn JY, Schwarz JK, Piwnica-Worms H, et al. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 2000;60(21):5934–5936. PubMed PMID: WOS:000165230300006.
   PubMed Web of Science ®Google Scholar
• Roma A, Rota SG, Spagnuolo PA. Diosmetin induces apoptosis of acute myeloid leukemia cells. Mol Pharm. 2018;15(3):1353–1360. Epub 2018/ 02/08. PubMed PMID: 29412683.
   PubMedGoogle Scholar
• Liu J, Ren H, Liu B, et al. Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells. Oncol Lett. 2016;12(6):4385–4392. Epub 2017/ 01/20. PubMed PMID: 28101201; PubMed Central PMCID: PMCPMC5228182.
   PubMed Web of Science ®Google Scholar
• Liu B, Shi Y, Peng W, et al. Diosmetin induces apoptosis by upregulating p53 via the TGF-beta signal pathway in HepG2 hepatoma cells. Mol Med Rep. 2016;14(1):159–164. Epub 2016/ 05/14. PubMed PMID: 27176768; PubMed Central PMCID: PMCPMC4918616.
   PubMed Web of Science ®Google Scholar
• Chen X, Wu Q, Chen Y, et al. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition. Br J Pharmacol. 2019;176(12):2079–2094. Epub 2019/ 03/03. PubMed PMID: 30825187; PubMed Central PMCID: PMCPMC6534779.
   PubMed Web of Science ®Google Scholar
• Choi J, Lee DH, Park SY, et al. Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer. Biomed Pharmacother. 2019;117:109091. Epub 2019/ 06/23. PubMed PMID: 31228803.
   PubMed Web of Science ®Google Scholar
• Ge A, Ma Y, Liu YN, et al. Diosmetin prevents TGF-beta1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways. Life Sci. 2016;153:1–8. Epub 2016/ 04/23. PubMed PMID: 27101925.
   PubMed Web of Science ®Google Scholar
• Yan Y, Liu X, Gao J, et al.Inhibition of TGF-beta Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Dracocephalum peregrinum L. Molecules. 2020; 25(1). Epub 2020/ 01/08. PubMed PMID: 31906574; PubMed Central PMCID: PMCPMC6982745. DOI:10.3390/molecules25010192.
   Web of Science ®Google Scholar
• Chen X, Wu Q, Chen Y, et al. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non‐small cell lung cancer cells via Nrf2 inhibition. Br J Pharmacol. 2019;176(12):2079–2094.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yan Y, Xiao L, et al. Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway. PloS One. 2017;12(4):e0175977. Epub 2017/ 04/18. PubMed PMID: 28414793; PubMed Central PMCID: PMCPMC5393875.
   PubMed Web of Science ®Google Scholar
• Liu Q, Turner KM, Alfred Yung WK, et al. Role of AKT signaling in DNA repair and clinical response to cancer therapy. Neuro Oncol. 2014;16(10):1313–1323. Epub 2014/ 05/09. PubMed PMID: 24811392; PubMed Central PMCID: PMCPMC4165418.
   PubMed Web of Science ®Google Scholar
• Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11(4):239–253. Epub 2011/ 03/25. PubMed PMID: 21430696.
   PubMed Web of Science ®Google Scholar
• Ozpiskin OM, Zhang L, Li JJ. Immune targets in the tumor microenvironment treated by radiotherapy. Theranostics. 2019;9(5):1215–1231. Epub 2019/ 03/15. PubMed PMID: 30867826; PubMed Central PMCID: PMCPMC6401500.
   PubMed Web of Science ®Google Scholar
• Nout RA, van de Poll-franse LV, Lybeert ML, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29(13):1692–1700. Epub 2011/ 03/30. PubMed PMID: 21444867.
   PubMed Web of Science ®Google Scholar
• Durant ST, Zheng L, Wang Y, et al. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv. 2018;4(6):eaat1719. Epub 2018/ 06/26. PubMed PMID: 29938225; PubMed Central PMCID: PMCPMC6010333.
   PubMed Web of Science ®Google Scholar
• Laird JH, Lok BH, Ma J, et al. Talazoparib is a potent radiosensitizer in small cell lung cancer cell lines and xenografts. Clin Cancer Res. 2018;24(20):5143–5152. Epub 2018/ 06/28. PubMed PMID: 29945991; PubMed Central PMCID: PMCPMC6742772.
   PubMed Web of Science ®Google Scholar
• King HO, Brend T, Payne HL, et al. RAD51 is a selective dna repair target to radiosensitize glioma stem cells. Stem Cell Reports. 2017;8(1):125–139. Epub 2017/ 01/12. PubMed PMID: 28076755; PubMed Central PMCID: PMCPMC5233453.
   PubMed Web of Science ®Google Scholar
• Auguste A, Genestie C, De Bruyn M, et al. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative. Modern Pathol. 2018;31(12):1851–1861. PubMed PMID: WOS:000451623400008.
   PubMed Web of Science ®Google Scholar
• Lomnytska MI, Becker S, Gemoll T, et al. Impact of genomic stability on protein expression in endometrioid endometrial cancer. Br J Cancer. 2012;106(7):1297–1305. Epub 2012/ 03/15. PubMed PMID: 22415234; PubMed Central PMCID: PMCPmc3314786.
   PubMed Web of Science ®Google Scholar